Christy Carlson Romano Joins Sunnyside to Help Millions Take Control of Their Drinking Before Rock Bottom

Christy Carlson Romano Joins Sunnyside to Help Millions Take Control of Their Drinking Before Rock Bottom

PR Newswire

Ten years into her sobriety, the actress and author becomes Chief Brand Advocate for the alcohol health company bringing medication and ongoing support to people who want to drink less or quit.

SAN FRANCISCO, Nov. 17, 2026 /PRNewswire/ — Sunnyside today announced that actress and author Christy Carlson Romano has joined the company as Chief Brand Advocate, bringing a personal mission to its medication-based approach to alcohol care: helping more people find support before their drinking becomes a crisis.

Christ Carlson Romano is now Sunnyside's Chief Brand Advocate

Christy Carlson Romano Joins Sunnyside to Help Millions Take Control of Their Drinking Before Rock Bottom

Romano, known for Even Stevens, Kim Possible and Cadet Kelly, has spoken openly about her drinking and sobriety in her newly published memoir, Once Upon a Trainwreck: The Fall and Rise of a Child Star. She joins Sunnyside with a stake in the company and a new answer for the people who already turn to her for help.

“People DM me about their drinking a lot. For years, the best I could offer was ‘one day at a time.’ Now I finally have a new answer that might help,” said Romano. “Sunnyside is the program I wish had existed when I first started to think something was wrong with my drinking.”

The announcement follows a major expansion of Sunnyside’s clinical offering. In the past 18 months, Sunnyside Med has treated more than 15,000 people with clinician-prescribed medication and ongoing behavior-change support. On November 12, the company launched new programs pairing semaglutide, a GLP-1 medication, with naltrexone. Since 2020, Sunnyside has helped more than 600,000 people work toward a healthier relationship with alcohol.

As Chief Brand Advocate, Romano will use her social channels and public platform to raise awareness of medication-based alcohol care and help people feel more comfortable seeking support. Her own path has been sobriety. Through Sunnyside, she wants people to know they can get help whether their goal is drinking less or quitting.

The need is substantial. An estimated 27.1 million American adults had alcohol use disorder in 2024, yet only 2.4% received medication-assisted treatment for it, according to the National Institute on Alcohol Abuse and Alcoholism.

Sunnyside Med makes that care available online, with a clinical evaluation, prescription medication when appropriate, and ongoing support from a clinical team. Naltrexone can help reduce alcohol cravings and make drinking less rewarding. Members also receive daily planning and tracking tools, coaching, community, and live online meetings to help them understand and change the habits behind their drinking. Care is provided from home, and insurance is not required.

Among active members of Sunnyside Med’s naltrexone program:

  • 81% drank less within three months.
  • 88% of those who started with heavy-drinking days had fewer heavy-drinking days within three months.
  • Average weekly drinking fell by 40% within three months.
  • More than one in three cut their drinking in half within three months.

“We’re opening a new chapter in alcohol care, where people can get medication and real support before drinking becomes a crisis,” said Nick Allen, co-founder and CEO of Sunnyside. “Christy understands how hard it can be to ask for help. People already trust her enough to tell her what’s going on with their drinking, and she wants them to know there are options. That’s exactly the conversation we need more people to have.”

Sunnyside’s new GLP-1 programs expand those options. Both pair semaglutide with naltrexone under clinician-guided care, supported by the full Sunnyside Med behavior-change program. The medications work through different mechanisms, giving clinicians another option to consider for eligible members as research into GLP-1s and alcohol continues to develop.

Romano’s appointment brings a familiar voice to that changing treatment landscape. Her announcement draws directly on the conversations she already has with people who are worried about their drinking and unsure where to turn.

“I got sober before Sunnyside existed. It was really hard, and I waited until things got really bad for me,” said Romano. “Whether you want to drink less or quit, they take an evidence-based approach to help you reach your goals, with optional medication, and clinical support along the way.”

Learn more at sunnyside.co.

Medication information

Semaglutide is not FDA-approved for alcohol use disorder. Sunnyside Med’s compounded medications are not FDA-approved or reviewed by FDA for safety, effectiveness or quality. Published studies did not test Sunnyside’s formulations or medication pairing.

Data notes

Results reflect separate internal observational analyses of selected active naltrexone-program members’ self-reported drinking at weeks 8–12 (sample sizes: 840–2,334). Heavy-drinking days meant five or more drinks. These are not GLP-1 program results. Individual results vary. Methodology is available upon request.

Media contact: Nick Allen, nick@sunnyside.co

About Sunnyside

Sunnyside is an alcohol health company on a mission to change the way the world drinks alcohol, helping millions on the path to a happier, healthier life. Since 2020, its app, coaching, and community have helped more than 600,000 people work toward a healthier relationship with alcohol. Sunnyside Med adds clinician-prescribed medication and ongoing clinical care for people who want to drink less or quit.

Sunnyside

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/christy-carlson-romano-joins-sunnyside-to-help-millions-take-control-of-their-drinking-before-rock-bottom-302941307.html

SOURCE Sunnyside